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Amyloid assemblies are associated with several debilitating human 
disorders. Understanding the intra- and 
extracellular assembly of normally sol-
uble proteins and peptides into amyloid 
aggregates and how they disrupt normal 
cellular functions is therefore of para-
mount importance. In a recent report, 
we demonstrated a striking relationship 
between reduced fibril length caused by 
fibril fragmentation and enhanced ability 
of fibril samples to disrupt membranes 
and to reduce cell viability. These find-
ings have important implications for our 
understanding of amyloid disease in that 
changes in the physical dimensions of 
fibrils, without parallel changes in their 
composition or molecular architecture, 
could be sufficient to alter the biological 
responses to their presence. These conclu-
sions provide a new hypothesis that the 
physical dimensions and surface interac-
tions of fibrils play key roles in amyloid 
disease. Controlling fibril length and 
stability toward fracturing, and thereby 
the biological availability of fibril mate-
rial, may provide a new target for future 
therapeutic strategies towards combating 
amyloid disease.
Background to Amyloid Assembly 
and Cytotoxicity
The assembly of normally soluble proteins 
and peptides into fibrillar amyloid deposits 
and the cytotoxicity coupled with amyloid 
aggregation are associated with numerous 
devastating human disorders, including 
type II diabetes mellitus and Alzheimer, 
Parkinson and Creutzfeldt-Jakob diseases.1 
The assembly of the fibrillar aggregates, 
characteristic of amyloid disease, is believed 
to occur through nucleated polymerisation 
and fibril elongation that involves the 
addition of assembly-competent precur-
sors to fibrillar ends.2 Different oligomeric 
species that accumulate during the early 
stages of fibril assembly have been sug-
gested as the origin of the cytotoxicity 
associated with amyloid disease, and fibril 
fragmentation that shortens fibril length 
and increases the number of fibrils is a key 
secondary process that accelerates amyloid 
assembly.2,3 Amyloid fibrils are thought 
to be mechanically and biologically stable 
assemblies.4 They have a characteristic 
cross-β core-architecture,5 usually appear 
as long-straight and unbranched structures 
with width in the order of ∼10 nm and 
lengths up to several micrometres,4,6,7 and 
can be formed from potentially all proteins 
and peptides irrespective of their amino 
acid sequence.8 Despite being formed by 
physiologically available proteins or pep-
tides in situ, amyloid fibrils can be regarded 
as stable, persistent, nano-scale particles 
that can produce serious threats to cellular 
integrity and function when produced in 
an uncontrolled manner in vivo, similar 
to other man-made or naturally occur-
ring nano-scale materials whose proper-
ties depend on their size.9 The physical 
attributes of amyloid fibrils such as length, 
width and surface area may therefore play 
important roles in determining how these 
assemblies affect biological processes and 
elicit cellular responses.
In recent years, pre-fibrillar oligom-
ers have been implicated as the primary 
cytotoxic species associated with amy-
loid formation.10-13 Efforts to identify the 
species involved in mediating the cyto-
toxicity associated with amyloid disor-
ders resulted, however, in varied reports 
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as potential key properties affecting the 
behaviours of amyloid fibrils in disease.
Fibril Fragmentation and Length 
Dependent Properties in Amyloid 
Assembly and Cytotoxicity
The finding that fibril samples are capable 
of disrupting model liposome membranes 
shown in our study17 is consistent with the 
hypothesis that fibril-associated cytotoxic-
ity may result from the damage of cellular 
membranes, a phenomenon suggested in 
previous studies to account for the cyto-
toxicity associated with pre-fibrillar oligo-
meric species.19 The molecular mechanism 
of damage remains unclear, and it is 
possible that fibrils and oligomers act by 
similar or distinct mechanisms. Several 
possiblities exist, including the creation of 
pores, through membrane thinning or via 
the lowering of the dielectric barrier.19 The 
plasma membrane could be a major target 
for the interaction of fibrils with cells, as it 
is accessible to extracellular fibrils as well as 
those formed within the cytoplasm of cells. 
However, deleterious cellular responses 
may result from the interaction between 
fibrils and lipid membranes at other sites. 
Indeed, some fibrils are formed intra-
cellularly, whereas other extracellularly 
formed fibrils, if a suitable size, may be 
internalised by cells.20,21 Disruption to 
intracellular membranes, predominantly 
by fragmented fibrils, could therefore pro-
vide a plausible mechanism for fibril-
associated-cytotoxcity.
Fibril fragmentation has recently been 
implicated as a key process involved in 
determining the kinetics of amyloid 
assembly.2,3 Under conditions in which 
nucleation is slow, as in the case of amy-
loid formation in disease, the rate of fibril 
growth can be drastically accelerated by 
the process of fragmentation through the 
resulting creation of extension-competent 
surfaces when fibrils break. Fragmentation 
of fibril particles has also been shown to 
affect the phenotype strength of different 
yeast prion strains, as increased brittleness 
of fibrils increases the efficiency of prion 
infection.3 The increase in both the rate 
of amyloid fibril assembly and the phe-
notype strength of prions formed from 
fibrils that are more readily fragmented 
is a direct consequence of the division of 
where the initial extension rate is directly 
proportional to the relative increase in 
the number of fibril particles as fibrils 
fragment (Fig. 1A), as expected for an 
assembly mechanism involving monomer 
addition to fibrillar ends.2 Importantly 
however, when added to liposomes formed 
from 80% (w/w) phosphatidyl choline 
and 20% (w/w) phosphatidyl glycerol 
within which 50 mM carboxyfluorescein 
had been encapsulated, the fibril samples 
were found to be able to cause membrane 
disruption, resulting in the release of 
the encapsulated dye. Most remarkably, 
however, the samples containing shorter 
fibrils were found to disrupt the lipo-
some membranes more efficiently than 
their longer counterparts (Fig. 1A, center 
plot). The efficiency of dye release caused 
by these samples had a complex relation-
ship with fibril length that is not ade-
quately described solely by the increase 
in the number of fibrils as fragmentation 
proceeds. This contrasts markedly with 
the simple relationship between the num-
ber of fibril particles and their seeding 
efficiency (Fig. 1A, lower plot), suggest-
ing that the surface area of ends (propor-
tional to the number of fibrils) as well 
as surfaces along the fibril axis together 
affect fibril-membrane interactions. The 
ability of fibril samples to cause a reduc-
tion in cell viability was also assayed using 
3-(4,5-dimethylthiazol-2yl)-2,5-diphe-
nyltetrazolium bromide (MTT) assays. 
The results of the MTT assays showed 
that samples containing shorter fibrils 
reduced cell viability of SH-SY5Y and 
RAW 264.7 cells to a greater extent than 
samples containing longer fibrils (Fig. 
1B). The same length-dependent effect 
on liposome membrane integrity and on 
cell viability assayed by MTT was also 
observed for fibrils formed from lysozyme 
or α-synuclein (Fig. 1B). The results 
therefore demonstrate the striking find-
ing that shorter fibrillar samples show an 
enhanced cytotoxic potential compared 
with their longer counterparts despite 
possessing indistinguishable molecular 
architecture. Fibril length thus inversely 
correlates with the ability to disrupt 
membranes and to reduce cell viabil-
ity. These findings bring fragmentation, 
and the physical dimensions and surface 
interactions of amyloid fibrils, into focus 
that have implicated both the soluble 
pre-fibrillar oligomers and the fibrillar 
products of assembly14-16 as the primary 
cytotoxic species. Taken as a whole, these 
reports raise the possibility that the deter-
minants of cytotoxicity may not always 
be associated with a single type of spe-
cies. These reports also suggest that fibrils 
themselves or fibril-associated species (i.e., 
species dynamically associated with fibrils 
through direct exchange) may also possess 
cytotoxic potential, and fibrils should not 
be dismissed as merely the inert products of 
amyloid assembly. The physical attributes 
of fibrillar aggregates that influence sur-
face interactions and biological availabil-
ity may therefore play an important role in 
disease. Such properties could contribute 
to the variety of different responses of cells 
to the presence of amyloid deposits.
Relationship between Fibril 
Length and Fibril-Associated 
Cytotoxicity
To investigate the impact of fibrils on the 
cellular responses to amyloid, in particular 
how the responses are related to the phys-
ical dimensions of the fibrils, we charac-
terised the length distribution of fibrils 





m) in detail by tapping-mode atomic 
force microscopy (TM-AFM) single par-
ticle image analysis.17,18 In parallel, we 
assessed the ability of these fibril samples 
to seed the growth of new fibrils, to dis-
rupt liposome membranes and to alter 
cell viability.17 Through the application 
of carefully controlled fragmentation of 
preformed fibrils of β
2
m by mechani-
cal agitation using a custom made stir-
rer equipped with a revolution-counter 
on the rotor-axis, we generated fibril 
samples containing an identical monomer 
equivalent concentration that had indis-
tinguishable molecular architecture,17 but 
distinct length distributions (Fig. 1A, 
upper plot). When fibril growth of fresh 
monomer solutions of β
2
m was seeded by 
each of these samples, the initial rate of 
fibril growth was shown to be enhanced 
for fibril samples containing short fibrils 
compared with their longer counterparts 
(Fig. 1A, lower plot). The increase in 
the seeding efficiency as fragmentation 
proceeds is well described by a model 
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potential, in direct dynamic exchange 
with fibril ends.22 Reduction in the physi-
cal dimensions of fibrils following frag-
mentation could also result in enhanced 
fibril-membrane surface interactions 
and/or reduced fibril-fibril interactions 
that may increase the biological availabil-
ity and overall surface activity of fibril 
deposits. Reducing the overall fibril size 
could also lead to increased internalisa-
tion by cells20 or increased membrane 
penetration of extracellular fibrils, giv-
ing them an access to potentially more 
vulnerable internal membranes. The 
diffusion rates of shorter fibril particles 
by fibril fragmentation may together con-
tribute to enhance the cytotoxic potential 
of fibrillar material.
As fibril fragmentation proceeds for 
both intracellular and extracellular amy-
loid fibrils, the increase in the number of 
fibril particles and the decrease in their 
dimensions result in a number of differ-
ent effects. Fragmentation increases the 
number of extension-competent surfaces 
at fibril ends, leading to an increase in 
the fibril extension rate.2 The increase 
in the number of fibrils, in parallel, will 
raise the dissociation frequency of solu-
ble species, possibly possessing cytotoxic 
fibril particles caused by fragmentation, 
which results in an increased number of 
extension-competent sites. Notably how-
ever, fibril fragmentation also reduces fibril 
length, leading to a reduction of the sur-
face area along the fibril axis per particle. 
This size-altering effect of fragmentation 
modifies the ability of fibrils to interact 
with surfaces, including biological mem-
branes or other fibril particles, even in the 
absence of changes in the composition or 
the molecular architecture of fibril mate-
rial. The combined effects of decreasing 
the length of individual fibrils and increas-
ing the number of fibrillar particles caused 
Figure 1. the effect of fibril fragmentation on length, seeding capability, capacity to cause membrane disruption and cytotoxic potential of fibril 
samples. (a) Change in weight average fibril length as measured using tM-aFM single particle image analysis18 (upper), ability to disrupt a model lipid 
membrane formed from 80% (w/w) phosphatidyl choline and 20% (w/w) phosphatidyl glycerol (middle), and initial fibril extension rate when added 
to fresh monomer solutions (lower) as function of the length of time a preformed β2m fibril sample was fragmented by stirring at 1,000 r.p.m. For the 
initial fibril extension rate (lower) and dye release efficiency (middle), calculated curves based on a model where the observed changes are directly 
proportional to the relative increase in the number of fibril particles as fibrils fragment (dashed lines), or best fit non-linear power-law relationship 
(solid lines) are also shown in each case. the difference in the two curves in the case of dye release efficiency illustrates that membrane disruption 
follows a more complex relationship with fibril length  than fibril extension rate, in a manner that cannot be described solely by the increase in the 
number of fibrils as fragmentation proceeds. (B) ability to disrupt liposome membranes (dye release assay), and to decrease cell viability (Mtt assay) 
by samples containing short (white bars) or long (grey bars) fibrils of lysozyme (upper plot), α-synuclein (center plot) or β2m (lower plot). relative dye 
release efficiency and relative cell viability were normalised against the effect of long fibrils for comparison. the error bars represent one standard 
error. negative stain transmission electron micrographs of the fibril samples (top: lysozyme, centre: α-synuclein, bottom: β2m) are shown to the right, 
with scale bars representing 200 nm. In each case, the fragmented sample is shown below its unagitated counterpart. (Data were originally published 
in the Journal of Biological Chemistry, Xue et al. Fibril fragmentation enhances amyloid cytotoxicity. J Biol Chem 2009; 284:34272–82.17 © the american 
Society for Biochemistry and Molecular Biology).
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disease. Firstly, fibril fragmentation pro-
vides a mechanism by which fibril load can 
be rapidly increased and fibrillar species 
of reduced dimensions with enhanced 
cytotoxicity are created. This then leads 
to the hypothesis that fibril fragmentation 
may be a key process in amyloidosis, has-
tening the progression of amyloid disease 
and enhancing the deleterious cellular 
response to the presence of amyloid fibrils. 
Environmental factors in vivo that affect 
fibril fragmentation may therefore modu-
late the rate of development of amyloid 
disease, even for fibrils of the same com-
position and architecture. Such fragmenta-
tion processes in vivo could be caused by 
direct mechanical stress, thermal motion, 
or the activity of chaperones such as 
Hsp104, which has a known ability to frag-
ment fibril samples.23 On the other hand, 
molecular changes such as alteration of the 
amino acid sequence of amyloid precursors 
as a result of genetic mutations may alter 
the mechanical properties of fibrils and/or 
their stability toward fragmentation. This 
could help to explain the different rates 
of onset of amyloid disease for different 
protein sequences. In order to further the 
understanding of amyloid disease, precise 
information regarding the environmental 
factors that effect the mechanical prop-
erties of amyloid fibrils,4 as well as the 
molecular determinants of fibril structure, 
stability and dynamics,6,7,24 and how these 
properties alter the fragmentation rate, are 
therefore critical. The precise rates of fibril 
fragmentation for different amyloid sys-
tems or different amyloidogenic sequences 
represent the key parameter that must 
be characterised in this case. The rates of 
fragmentation (the division/replication of 
fibril particles), with the rates of nucle-
ation (the creation/infection of new fibril 
particles), and extension (the growth of 
existing fibril particles), represent the key 
triad of processes that together determines 
the size distributions of amyloid species, 
and may dictate the detailed progress of 
amyloid disease similar to analogous pro-
cesses involving microbial and viral infec-
tious and/or pathogenic particles.
Secondly, since fibril length is a crucial 
parameter in determining the type and the 
extent of cellular responses to the presence 
of amyloid, characterisation of the length 
distribution of fibrils becomes crucial to 
Implications of Fibril  
Fragmentation, Physical  
Dimensions and Surface  
Interactions for Amyloid Disease
The results of our study on the bio-
logical consequence of changes in fibril 
length caused by fragmentation have sev-
eral important implications for amyloid 
are also enhanced compared with their 
longer counterparts, which could further 
increase their biological activity. In all of 
these scenarios, a decrease in the physi-
cal dimensions of fibrils would lead to an 
enhancement of the capacity to increase 
fibril load, as well as to an enhancement 
of the cytotoxic potential of fibril material 
(Fig. 2).
Figure 2. Schematic illustration of the landscape of fibril assembly and fragmentation in relation 
to the mechanism of fibril associated cytotoxicity. an assembly landscape is illustrated by fibril 
load plotted against fibril length (upper). the intensity of the red background colour represents 
the cytotoxic potential. the thick red arrow (I) in the landscape illustrates a representative fibril 
assembly pathway that would occur in the presence of fibril fragmentation or where nucleation is 
rapid relative to elongation, resulting in a rapid formation of fibrils with short length distributions. 
the presence of these short fibrils could lead to enhanced cytotoxicity through decreased fibril-
fibril interactions (1) and/or increased fibril-membrane interaction (2). the increased interaction 
between short fibrils and membrane surfaces could result in membrane damage and a cytotoxic 
response by fibrils penetrating the membrane (3), growing on the membrane surface (4) or releas-
ing cytotoxic species (5). the thin blue arrow in the assembly landscape (II) illustrates a represen-
tative fibril assembly pathway in which little fibril fragmentation occurs or where nucleation is 
slow relative to elongation, which results in a slow increase of fibril load and the formation of long 
fibrils. these long fibrils are likely to be less biologically available through increased fibril-fibril 
interactions (6), decreased interaction with membranes (7) and/or decreased ability of fibrils to 
pass through the membrane or be taken up by a cell (8) compared with their short counterparts. 
Fragmentation post-assembly (either mechanical or via chaperones) shortens the average fibril 
length and thereby enhances the cytotoxic potential without changes to fibril structure (blue to 
red horizontal arrows III). (Figure was originally published in the Journal of Biological Chemistry, 
Xue et al. Fibril fragmentation enhances amyloid cytotoxicity. J Biol Chem 2009; 284:34272–82.17 © 
the american Society for Biochemistry and Molecular Biology).
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Implications for Therapeutic  
Approaches to Amyloid Disease
Our study has indicated that both the time 
course of amyloidogenesis and the cel-
lular responses to the presence of amyloid 
fibrils depends on the extent of fibril frag-
mentation. The length distribution and 
the surface properties of amyloid fibrils 
could thus be key parameters in amyloid 
disease. These conclusions suggest that 
the hallmarks of amyloid disease do not 
only simply depend on the quantity of 
amyloid deposits, or the nature of amy-
loid precursors, but also on the biologi-
cal availability of amyloid aggregates and 
their surfaces properties. Thus, therapeu-
tic strategies that reduce the amount of 
aberrant surfaces presented by amyloid 
fibrils, or which reduce the biological 
availability of amyloid fibrils in general 
could be successful in limiting the growth 
rate of amyloid deposits as well as reduc-
ing the cytotoxic effects of amyloid itself. 
For example, strategies to stabilise fibrils 
against fracturing, to induce clumping of 
fibril fragments, and/or to coat the surfaces 
of amyloid fibrils or fibrillar deposits could 
all lead to reduction of the deleterious 
biological activities associated with the 
presence of amyloid. These strategies may 
prove to be powerful new directions for 
future therapies to combat the devastating 
consequences of amyloid disease.
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either through their end surfaces or 
through their surface along the fibril axis. 
On the other hand, both types of surfaces 
may be able to interact concomitantly 
with membranes for fibrils that are shorter 
than the size of cells or cellular compart-
ments (in the order of hundred nanome-
tres or shorter), possibly giving rise to 
enhanced interactions. Thus, for fibrils 
less than 100 nm in length that are exten-
sively populated in fragmented samples, 
their larger end surface area per weight 
material and smaller area per fibril paral-
lel to the fibril axis may result in particles 
with physical dimensions more optimal for 
disrupting membranes. In addition, due to 
the length dependence of fibril-fibril inter-
actions, long fibrils are likely to be more 
prone to entangle and form clusters or 
networks that are less biologically active 
than their unclustered counterparts. For 
example, the β
2
m fibril samples used in 
our study containing, on average, 1.4 µm 
fibrils17 display gel-like properties (Fig. 3, 
sample B). By contrast, the same sample 
fragmented to an average length of ∼400 
nm (Fig. 3, sample C) displays properties 
similar to a dilute aqueous solution (Fig. 
3, sample A). The type, strength and bal-
ance of surface interactions between amy-
loid species, as well as between amyloid 
species and membranes, proteins or other 
macromolecules may therefore be the cru-
cial determinates of cellular responses to 
the presence of amyloid fibrils.
studies of amyloid disease. Information 
regarding fibril length will also be vital 
for characterisation of the process of fibril 
fragmentation, as fragmentation rates 
are themselves fibril length dependent.25 
While length (but not height/width) was 
varied through controlled fragmentation 
in the case of β
2
m in our recent report,17 
other physical dimensions may be signifi-
cantly perturbed as well in vivo. Thus, 
methods capable of characterising the 
size distributions of amyloid particles in 
general, such as light scattering,26 sedi-
mentation,27 fluorescence (correlation 
spectroscopy, or total internal reflection 
microscopy28), nuclear magnetic reso-
nance (diffusion ordered spectroscopy, 
NMR-DOSY)24,29 and imaging (electron 
microscopy or TM-AFM18), are para-
mount for the study of amyloid disease. In 
particular, direct imaging methods such 
as TM-AFM may prove to be particu-
larly useful, at least for studies in vitro, as 
detailed model free distribution data can 
be obtained through single particle detec-
tion and measurements.18
Thirdly, it is evident from our study 
that not only do different types of aggre-
gation species give rise to different biologi-
cal responses, but changes in the physical 
dimensions of aggregates alone, without 
parallel changes in their composition or 
molecular architecture, may be sufficient 
to alter the biological responses to amyloid. 
Based on our experimental results, the 
biological responses that are dependent on 
the dimensions of amyloid aggregates are 
likely mediated by surface interactions, for 
example between fibrils and membranes 
and/or between fibrils themselves. Surface 
interactions involving nano-particles are 
known to cause the adsorption of pro-
teins on to particle surfaces depending 
on the characteristics, physical geometry 
and as the area to mass ratio of the sur-
faces presented by the nano-particles.30-32 
Nano-scale particles of amyloid spe-
cies may behave in an analogous man-
ner, as the surfaces presented by amyloid 
aggregates may be entirely different than 
their precursor proteins or peptides, and 
therefore capable of eliciting new biologi-
cal responses. Given the rigidity of fibrils 
(which have a persistence length of at least 
micrometers33), long fibrils (∼micrometers 
in length) could interact with membranes 
Figure 3. Photographs of a tube with sample solution containing (a) water, (B) unagitated long-
straight β2m fibrils displaying gel-like properties and (C) long-straight β2m  fibrils that have been 
fragmented to an average length of ∼400 nm through mechanical stirring. Sample tubes are 
shown lying down (left photo) or standing in an up side down position (right photo). an arrow 
indicates the position of the meniscus in each case. the unagitated fibril sample (B) is demonstrat-
ing gel-like properties as the meniscus does not follow the tilt of the sample tube (left), nor does 
the solution readily flow compared with water or fragmented fibril sample (right) likely due to 
increased viscosity.
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